Dexametasona e ivermectina na estrongiloidíase experimental : aspectos parasitológicos e alterações morfofuncionais no trato gastrintestinal de camundongos

Detalhes bibliográficos
Autor(a) principal: Devotte, Nasciane Correa
Data de Publicação: 2022
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional da UFMT
Texto Completo: http://ri.ufmt.br/handle/1/5289
Resumo: Dexamethasone is an immunosuppressive glucocorticoid and ivermectin is the antiparasitic of choice for strongyloidiasis. Experimental models using Strongyloides venezuelensis with compromised immunity can be used to understand the parasitehost relationship, as well as unravel the role of the gastrointestinal tract in this relationship. The objective was to evaluate the effects of dexamethasone and ivermectin on the gastrointestinal parasitological and morphofunctional aspects during experimental strongyloidiasis. BALB/c mice were randomly assigned to seven groups: Control (received saline and not infected); Sven (untreated and infected with S. venezuelensis); Dexa 2mg/Kg -SC (treated and uninfected); Sven+Dexa (treated and infected with S. venezuelensis); IVM 200 μg /Kg -VO (treated and uninfected); Sven+IVM (infected with S. venezuelensis and treated with ivermectin); Sven+Dexa+IVM (infected with S. venezuelensis, treated with dexamethasone and ivermectin). Daily, there was weighing and counting of eggs per gram of feces. Weekly, feed intake, feed efficiency, faecal moisture, oro-anal transit time (TTOA) and fecal pellet elimination rate (TEPF) were determined by the Alternating Current Biosusceptometry (BAC) method. Adult worms were recovered from the intestine and organs, including lymphoids, were analyzed. All data were analyzed by ANOVA followed by Dunnett (p<0.05). The groups of animals that received dexamethasone showed reduced food consumption and weight, consequently, presenting negative feed efficiency. The Sven+IVM group showed a significant reduction in OPG only with the administration of 4 consecutive doses. Animals that received dexamethasone had a higher number of eggs eliminated by the end of the experiment, even when ivermectin (Sven+Dexa+IVM) was associated. Animals treated with ivermectin showed accelerated transit when compared to Control. Both drugs altered gastrointestinal motility, as well as the weight of lymphoid organs, relative length of the small intestine, size of the stomach and cecum, and stool moisture. Thus, understanding the effects of these drugs alone or in combination on parasitic infection and GI motility is important to determine the most appropriate therapeutic choices in each situation.
id UFMT_bcacc7985dec61cd73c80f18c1af10ba
oai_identifier_str oai:localhost:1/5289
network_acronym_str UFMT
network_name_str Repositório Institucional da UFMT
repository_id_str
spelling Dexametasona e ivermectina na estrongiloidíase experimental : aspectos parasitológicos e alterações morfofuncionais no trato gastrintestinal de camundongosS. venezuelensisEstrongiloidíaseDexametasonaTrânsito gastrintestinalCNPQ::CIENCIAS BIOLOGICAS::IMUNOLOGIAS. venezuelensisStrongyloidiasisDexamethasoneGastrointestinal transitDexamethasone is an immunosuppressive glucocorticoid and ivermectin is the antiparasitic of choice for strongyloidiasis. Experimental models using Strongyloides venezuelensis with compromised immunity can be used to understand the parasitehost relationship, as well as unravel the role of the gastrointestinal tract in this relationship. The objective was to evaluate the effects of dexamethasone and ivermectin on the gastrointestinal parasitological and morphofunctional aspects during experimental strongyloidiasis. BALB/c mice were randomly assigned to seven groups: Control (received saline and not infected); Sven (untreated and infected with S. venezuelensis); Dexa 2mg/Kg -SC (treated and uninfected); Sven+Dexa (treated and infected with S. venezuelensis); IVM 200 μg /Kg -VO (treated and uninfected); Sven+IVM (infected with S. venezuelensis and treated with ivermectin); Sven+Dexa+IVM (infected with S. venezuelensis, treated with dexamethasone and ivermectin). Daily, there was weighing and counting of eggs per gram of feces. Weekly, feed intake, feed efficiency, faecal moisture, oro-anal transit time (TTOA) and fecal pellet elimination rate (TEPF) were determined by the Alternating Current Biosusceptometry (BAC) method. Adult worms were recovered from the intestine and organs, including lymphoids, were analyzed. All data were analyzed by ANOVA followed by Dunnett (p<0.05). The groups of animals that received dexamethasone showed reduced food consumption and weight, consequently, presenting negative feed efficiency. The Sven+IVM group showed a significant reduction in OPG only with the administration of 4 consecutive doses. Animals that received dexamethasone had a higher number of eggs eliminated by the end of the experiment, even when ivermectin (Sven+Dexa+IVM) was associated. Animals treated with ivermectin showed accelerated transit when compared to Control. Both drugs altered gastrointestinal motility, as well as the weight of lymphoid organs, relative length of the small intestine, size of the stomach and cecum, and stool moisture. Thus, understanding the effects of these drugs alone or in combination on parasitic infection and GI motility is important to determine the most appropriate therapeutic choices in each situation.A dexametasona é um glicocorticoide de ação imunossupressora e a ivermectina é o anti-parasitário de escolha para estrongiloidíase. Modelos experimentais utilizando Strongyloides venezuelensis com imunidade comprometida pode ser empregado para compreensão da relação parasito-hospedeiro, bem como desvendar o papel do trato gastrintestinal nessa relação. Objetivou-se avaliar os efeitos da dexametasona e ivermectina sobre os aspectos parasitológicos e morfofuncionais gastrintestinais durante a estrongiloidíase experimental. Camundongos BALB/c foram distribuídos aleatoriamente em sete grupos: Controle (receberam solução salina e não foram infectados); Sven (não tratados e infectados com S. venezuelensis); Dexa 2mg/Kg - SC(tratados e não infectados); Sven+Dexa (tratados e infectados com S. venezuelensis); IVM 200 μg /Kg -VO (tratados e não infectados); Sven+IVM (infectados com S. venezuelensis e tratados com ivermectina); Sven+Dexa+IVM (infectados com S. venezuelensis, tratados com dexametasona e ivermectina). Diariamente, houve pesagem e contagem de ovos por grama de fezes. Semanalmente foram determinados o consumo de ração, eficiência alimentar, umidade das fezes, tempo de trânsito oroanal (TTOA) e taxa de eliminação de pelete fecal (TEPF) pelo método de Biosusceptometria de Corrente Alternada (BAC). Vermes adultos foram recuperados do intestino e órgãos, incluindo linfoides, foram analisados. Todos os dados foram analisados por ANOVA seguido por Dunnett (p<0,05). Os grupos de animais que receberam dexametasona, apresentaram redução de consumo alimentar e de peso, consequentemente, apresentando eficiência alimentar negativa. O grupo Sven+IVM apresentou redução significativa no OPG apenas com administração de 4 doses consecutivas. Animais que receberam dexametasona, apresentaram maior número de ovos eliminados até o final do experimento, mesmo quando a ivermectina (Sven+Dexa+IVM) foi associada. Animais tratados com ivermectina apresentaram trânsito acelerado quando comparados Controle. Ambos os fármacos alteraram a motilidade gastrintestinal, bem como o peso de órgãos linfoides, comprimento relativo do intestino delgado, tamanho do estômago e ceco e umidade das fezes. Dessa forma, compreender os efeitos desses fármacos isolados ou em associação sobre a infecção parasitária e motilidade GI é importante para determinar as escolhas terapêuticas mais adequadas em cada situação.Universidade Federal de Mato GrossoBrasilInstituto de Ciências Biológicas e da Saúde (ICBS) – AraguaiaUFMT CUA - AraguaiaPrograma de Pós-Graduação em Imunologia e Parasitologia Básicas e AplicadasAmérico, Madileine FrancelySales, Loyane Almeida Gamahttp://lattes.cnpq.br/6732524526124155http://lattes.cnpq.br/4097128727139521Américo, Madileine Francely267.529.008-41http://lattes.cnpq.br/4097128727139521Souto, Paula Cristina de Souza277.680.138-10http://lattes.cnpq.br/2161765071682282267.529.008-41034.335.661-94Rodrigues, Rosângela Maria726.641.346-04http://lattes.cnpq.br/6517252848392374Devotte, Nasciane Correa2024-02-29T15:14:40Z2022-05-042024-02-29T15:14:40Z2022-02-25info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisDEVOTTE, Nasciane Corrêa. Dexametasona e ivermectina na estrongiloidíase experimental: aspectos parasitológicos e alterações morfofuncionais no trato gastrintestinal de camundongos . 2022. 60 f. Dissertação (Mestrado em Imunologia e Parasitologia Básicas e Aplicadas) - Universidade Federal de Mato Grosso, Instituto de Ciências Biológicas e da Saúde, Barra do Garças, 2022.http://ri.ufmt.br/handle/1/5289porinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFMTinstname:Universidade Federal de Mato Grosso (UFMT)instacron:UFMT2024-03-05T07:01:21Zoai:localhost:1/5289Repositório InstitucionalPUBhttp://ri.ufmt.br/oai/requestjordanbiblio@gmail.comopendoar:2024-03-05T07:01:21Repositório Institucional da UFMT - Universidade Federal de Mato Grosso (UFMT)false
dc.title.none.fl_str_mv Dexametasona e ivermectina na estrongiloidíase experimental : aspectos parasitológicos e alterações morfofuncionais no trato gastrintestinal de camundongos
title Dexametasona e ivermectina na estrongiloidíase experimental : aspectos parasitológicos e alterações morfofuncionais no trato gastrintestinal de camundongos
spellingShingle Dexametasona e ivermectina na estrongiloidíase experimental : aspectos parasitológicos e alterações morfofuncionais no trato gastrintestinal de camundongos
Devotte, Nasciane Correa
S. venezuelensis
Estrongiloidíase
Dexametasona
Trânsito gastrintestinal
CNPQ::CIENCIAS BIOLOGICAS::IMUNOLOGIA
S. venezuelensis
Strongyloidiasis
Dexamethasone
Gastrointestinal transit
title_short Dexametasona e ivermectina na estrongiloidíase experimental : aspectos parasitológicos e alterações morfofuncionais no trato gastrintestinal de camundongos
title_full Dexametasona e ivermectina na estrongiloidíase experimental : aspectos parasitológicos e alterações morfofuncionais no trato gastrintestinal de camundongos
title_fullStr Dexametasona e ivermectina na estrongiloidíase experimental : aspectos parasitológicos e alterações morfofuncionais no trato gastrintestinal de camundongos
title_full_unstemmed Dexametasona e ivermectina na estrongiloidíase experimental : aspectos parasitológicos e alterações morfofuncionais no trato gastrintestinal de camundongos
title_sort Dexametasona e ivermectina na estrongiloidíase experimental : aspectos parasitológicos e alterações morfofuncionais no trato gastrintestinal de camundongos
author Devotte, Nasciane Correa
author_facet Devotte, Nasciane Correa
author_role author
dc.contributor.none.fl_str_mv Américo, Madileine Francely
Sales, Loyane Almeida Gama
http://lattes.cnpq.br/6732524526124155
http://lattes.cnpq.br/4097128727139521
Américo, Madileine Francely
267.529.008-41
http://lattes.cnpq.br/4097128727139521
Souto, Paula Cristina de Souza
277.680.138-10
http://lattes.cnpq.br/2161765071682282
267.529.008-41
034.335.661-94
Rodrigues, Rosângela Maria
726.641.346-04
http://lattes.cnpq.br/6517252848392374
dc.contributor.author.fl_str_mv Devotte, Nasciane Correa
dc.subject.por.fl_str_mv S. venezuelensis
Estrongiloidíase
Dexametasona
Trânsito gastrintestinal
CNPQ::CIENCIAS BIOLOGICAS::IMUNOLOGIA
S. venezuelensis
Strongyloidiasis
Dexamethasone
Gastrointestinal transit
topic S. venezuelensis
Estrongiloidíase
Dexametasona
Trânsito gastrintestinal
CNPQ::CIENCIAS BIOLOGICAS::IMUNOLOGIA
S. venezuelensis
Strongyloidiasis
Dexamethasone
Gastrointestinal transit
description Dexamethasone is an immunosuppressive glucocorticoid and ivermectin is the antiparasitic of choice for strongyloidiasis. Experimental models using Strongyloides venezuelensis with compromised immunity can be used to understand the parasitehost relationship, as well as unravel the role of the gastrointestinal tract in this relationship. The objective was to evaluate the effects of dexamethasone and ivermectin on the gastrointestinal parasitological and morphofunctional aspects during experimental strongyloidiasis. BALB/c mice were randomly assigned to seven groups: Control (received saline and not infected); Sven (untreated and infected with S. venezuelensis); Dexa 2mg/Kg -SC (treated and uninfected); Sven+Dexa (treated and infected with S. venezuelensis); IVM 200 μg /Kg -VO (treated and uninfected); Sven+IVM (infected with S. venezuelensis and treated with ivermectin); Sven+Dexa+IVM (infected with S. venezuelensis, treated with dexamethasone and ivermectin). Daily, there was weighing and counting of eggs per gram of feces. Weekly, feed intake, feed efficiency, faecal moisture, oro-anal transit time (TTOA) and fecal pellet elimination rate (TEPF) were determined by the Alternating Current Biosusceptometry (BAC) method. Adult worms were recovered from the intestine and organs, including lymphoids, were analyzed. All data were analyzed by ANOVA followed by Dunnett (p<0.05). The groups of animals that received dexamethasone showed reduced food consumption and weight, consequently, presenting negative feed efficiency. The Sven+IVM group showed a significant reduction in OPG only with the administration of 4 consecutive doses. Animals that received dexamethasone had a higher number of eggs eliminated by the end of the experiment, even when ivermectin (Sven+Dexa+IVM) was associated. Animals treated with ivermectin showed accelerated transit when compared to Control. Both drugs altered gastrointestinal motility, as well as the weight of lymphoid organs, relative length of the small intestine, size of the stomach and cecum, and stool moisture. Thus, understanding the effects of these drugs alone or in combination on parasitic infection and GI motility is important to determine the most appropriate therapeutic choices in each situation.
publishDate 2022
dc.date.none.fl_str_mv 2022-05-04
2022-02-25
2024-02-29T15:14:40Z
2024-02-29T15:14:40Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv DEVOTTE, Nasciane Corrêa. Dexametasona e ivermectina na estrongiloidíase experimental: aspectos parasitológicos e alterações morfofuncionais no trato gastrintestinal de camundongos . 2022. 60 f. Dissertação (Mestrado em Imunologia e Parasitologia Básicas e Aplicadas) - Universidade Federal de Mato Grosso, Instituto de Ciências Biológicas e da Saúde, Barra do Garças, 2022.
http://ri.ufmt.br/handle/1/5289
identifier_str_mv DEVOTTE, Nasciane Corrêa. Dexametasona e ivermectina na estrongiloidíase experimental: aspectos parasitológicos e alterações morfofuncionais no trato gastrintestinal de camundongos . 2022. 60 f. Dissertação (Mestrado em Imunologia e Parasitologia Básicas e Aplicadas) - Universidade Federal de Mato Grosso, Instituto de Ciências Biológicas e da Saúde, Barra do Garças, 2022.
url http://ri.ufmt.br/handle/1/5289
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade Federal de Mato Grosso
Brasil
Instituto de Ciências Biológicas e da Saúde (ICBS) – Araguaia
UFMT CUA - Araguaia
Programa de Pós-Graduação em Imunologia e Parasitologia Básicas e Aplicadas
publisher.none.fl_str_mv Universidade Federal de Mato Grosso
Brasil
Instituto de Ciências Biológicas e da Saúde (ICBS) – Araguaia
UFMT CUA - Araguaia
Programa de Pós-Graduação em Imunologia e Parasitologia Básicas e Aplicadas
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFMT
instname:Universidade Federal de Mato Grosso (UFMT)
instacron:UFMT
instname_str Universidade Federal de Mato Grosso (UFMT)
instacron_str UFMT
institution UFMT
reponame_str Repositório Institucional da UFMT
collection Repositório Institucional da UFMT
repository.name.fl_str_mv Repositório Institucional da UFMT - Universidade Federal de Mato Grosso (UFMT)
repository.mail.fl_str_mv jordanbiblio@gmail.com
_version_ 1804648530750472192